We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
76
Emerson Electric
EMR
$82.9B
$22.5M 0.28%
338,654
-207,045
-38% -$13.9M
TECH icon
77
Bio-Techne
TECH
$11.2B
$22.4M 0.28%
432,068
-1,600
-0.4% -$80.6K
ATVI
78
DELISTED
Activision Blizzard
ATVI
$22.3M 0.28%
473,561
-21,957
-4% -$1.01M
MELI icon
79
Mercado Libre
MELI
$91.3B
$21.7M 0.27%
35,629
-6,297
-15% -$3.5M
SAGE
80
DELISTED
Sage Therapeutics
SAGE
$21.6M 0.27%
118,300
-60,000
-34% -$10.2M
BLUE
81
DELISTED
bluebird bio
BLUE
$21.4M 0.27%
13,055
– –
ELV icon
82
Elevance Health
ELV
$81.9B
$21.3M 0.27%
75,757
+8
+0% +$2.19K
ALL icon
83
Allstate
ALL
$66.9B
$21.1M 0.26%
194,118
-53,853
-22% -$5.26M
XRAY icon
84
Dentsply Sirona
XRAY
$2.59B
$20.5M 0.26%
353,645
+127,913
+57% +$6.87M
PTC icon
85
PTC
PTC
$13.7B
$20.4M 0.25%
227,965
+13,269
+6% +$1.19M
NVDA icon
86
NVIDIA
NVDA
$5.01T
$20.4M 0.25%
4,983,320
-94,480
-2% -$392K
EL icon
87
Estee Lauder
EL
$29B
$20.3M 0.25%
111,482
+14,135
+15% +$2.41M
LLY icon
88
Eli Lilly
LLY
$1.07T
$20.2M 0.25%
183,054
+2,050
+1% +$241K
SGEN
89
DELISTED
Seagen Inc. Common Stock
SGEN
$20M 0.25%
289,780
+2,911
+1% +$204K
BHVN
90
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$20M 0.25%
457,799
+15,000
+3% +$846K
AMAT icon
91
Applied Materials
AMAT
$426B
$19.8M 0.25%
414,281
-273,848
-40% -$11.5M
BAP icon
92
Credicorp
BAP
$30.9B
$19.7M 0.25%
86,500
-9,200
-10% -$2.11M
MDLZ icon
93
Mondelez International
MDLZ
$77.7B
$19.1M 0.24%
309,491
+67,064
+28% +$3.48M
CMCSA icon
94
Comcast
CMCSA
$79.1B
$19.1M 0.24%
453,147
-56,587
-11% -$2.39M
BZUN
95
Baozun
BZUN
$144M
$19.1M 0.24%
384,000
-256,000
-40% -$11M
ZBH icon
96
Zimmer Biomet
ZBH
$17.7B
$19M 0.24%
167,208
+52,386
+46% +$6.14M
IONS icon
97
Ionis Pharmaceuticals
IONS
$9.35B
$18.8M 0.23%
293,200
-100,000
-25% -$7.07M
MET icon
98
MetLife
MET
$61B
$18.7M 0.23%
347,250
-44,896
-11% -$2.11M
LH icon
99
Labcorp
LH
$24.3B
$18.5M 0.23%
125,058
+12,205
+11% +$1.7M
MNST icon
100
Monster Beverage
MNST
$91.4B
$18.3M 0.23%
575,988
+205,992
+56% +$6.21M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.